Jade Biosciences (JBIO) Research & Development (2020 - 2026)
Jade Biosciences (JBIO) posted Research & Development of $36.1 million for Q1 2026, up 2303.53% on a QoQ basis from $1.5 million in Q4 2025, and up 80.06% year-over-year from $20.0 million in Q1 2025.
Jade Biosciences (JBIO) Research & Development (2020 - 2026) Analysis & Trends
Jade Biosciences' Research & Development history runs 7 years deep, the most recent figure standing at $36.1 million for Q1 2026.
- Quarterly Research & Development rose 80.06% year-over-year to $36.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.1 million (down 4.7% YoY) and the FY2025 annual result came in at $93.1 million, up 75.08% from the prior year.
- Research & Development was $36.1 million for Q1 2026 at Jade Biosciences, up from $1.5 million in the prior quarter.
- Across five years, Research & Development topped out at $36.1 million in Q1 2026 and bottomed at $1.5 million in Q4 2025.
- A 5-year average of $17.1 million and a median of $16.9 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 230.37% — and 2025, when it plunged 95.2%.
- Jade Biosciences' Research & Development stood at $12.2 million in 2022, then jumped by 45.76% to $17.8 million in 2023, then soared by 75.34% to $31.2 million in 2024, then plunged by 95.2% to $1.5 million in 2025, then jumped by 2303.53% to $36.1 million in 2026.
- Business Quant data shows JBIO's Research & Development at $36.1 million in Q1 2026, $1.5 million in Q4 2025, and $22.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 36.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 22.01 Mn |
| Jun 30, 2025 | 22.55 Mn |
| Mar 31, 2025 | 20.02 Mn |
| Dec 31, 2024 | 31.23 Mn |
| Sep 30, 2024 | 13.66 Mn |
| Jun 30, 2024 | 21.25 Mn |
| Mar 31, 2024 | 20.08 Mn |
| Dec 31, 2023 | 17.81 Mn |
| Sep 30, 2023 | 16.88 Mn |
| Jun 30, 2023 | 16.03 Mn |
| Mar 31, 2023 | 13.49 Mn |
| Dec 31, 2022 | 12.22 Mn |
| Sep 30, 2022 | 10.78 Mn |
| Jun 30, 2022 | 8.36 Mn |
| Mar 31, 2022 | 7.26 Mn |
| Dec 31, 2021 | 5.05 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Jun 30, 2021 | 4.33 Mn |